On the Hypes and Falls in Neuroprotection: Targeting the NMDA Receptor
- 2 October 2007
- journal article
- review article
- Published by SAGE Publications in The Neuroscientist
- Vol. 13 (6), 594-615
- https://doi.org/10.1177/1073858406296259
Abstract
Activation of the NMDA (N-methyl-D-aspartate) responsive subclass of glutamate receptors is an important mechanism of excitatory synaptic transmission. Moreover, NMDA receptors are widely involved in many forms of synaptic plasticity such as long-term potentiation (LTP) and long-term depression (LTD), which are thought to underlie complex tasks, including learning and memory. Dysfunction of these ligand-gated cation channels has been identified as an underlying molecular mechanism in neurological disorders ranging from acute stroke to chronic neurodegeneration in amyotrophic lateral sclerosis. Excessive glutamate levels have been detected following brain trauma and cerebral ischemia, resulting in an unregulated stimulation of NMDA receptors. These conditions are thought to elicit a cascade of excitation-mediated neuronal damage where massive increases in intracellular calcium concentrations finally trigger neuronal damage and apoptosis. Consistent with the hypothesis of NMDA receptors as essential mediators of excitotoxicity, the different functional domains of these ion channels have been identified as potential targets for neuroprotective agents. Following an initial hype on potential NMDA receptor therapeutics, the authors currently see a period of skepticism that, in reverse, appears to neglect the therapeutic potential of this receptor class. This review attempts a reappraisal of this important class of neurotransmitter receptors, with a focus on NMDA receptor heterogeneity, ligand binding domains, and candidate diseases for a potential neuroprotective therapy. NEUROSCIENTIST 13(6):594—615, 2007. DOI: 10.1177/1073858406296259Keywords
This publication has 99 references indexed in Scilit:
- Crystal structure of the kainate receptor GluR5 ligand‐binding core in complex with (S)‐glutamateFEBS Letters, 2005
- The Three-dimensional Structure of an Ionotropic Glutamate Receptor Reveals a Dimer-of-dimers AssemblyJournal of Molecular Biology, 2004
- Powerful antinociceptive effects of the cone snail venom-derived subtype-selective NMDA receptor antagonists conantokins G and TPain, 2003
- Allosteric interaction between the amino terminal domain and the ligand binding domain of NR2ANature Neuroscience, 2001
- Preincisional dextromethorphan decreases postoperative pain and opioid requirement after modified radical mastectomyCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1999
- Xenopus Oocytes express a unitary glutamate receptor endogenouslyJournal of Molecular Biology, 1997
- Prevention of trauma-induced neurodegeneration in infant and adult rat brain: Glutamate antagonistsMetabolic Brain Disease, 1996
- The influence of experimental ischaemia on protein kinase C and the GABAergic system in the rabbit retinaNeuropharmacology, 1995
- Unraveling the modular design of glutamate-gated ion channelsTrends in Neurosciences, 1995
- Proton inhibition of N-methyl-D-aspartate receptors in cerebellar neuronsNature, 1990